R. Goldwater

发表

Glycine Transporter Type 1 Occupancy by Bitopertin: a Positron Emission Tomography Study in Healthy Volunteers

James Robert Brašić, D. Wong, D. Umbricht, 2013, Neuropsychopharmacology.

A Phase 1, Randomized Ascending Single‐Dose Study of Antagonist Anti‐Human CD40 ASKP1240 in Healthy Subjects

D. Kowalski, J. Keirns, T. Sawamoto, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of ASP2408, a Potent Selective T‐Cell Costimulation Modulator After Single and Multiple Ascending Doses in Healthy Volunteers and RA Patients

Stanley B. Cohen, J. Keirns, A. Kivitz, 2016, Clinical pharmacology in drug development.

Pharmacokinetic Effects of Isavuconazole Coadministration With the Cytochrome P450 Enzyme Substrates Bupropion, Repaglinide, Caffeine, Dextromethorphan, and Methadone in Healthy Subjects

D. Kowalski, T. Yamazaki, R. Goldwater, 2016, Clinical pharmacology in drug development.

Dapagliflozin Added to Verinurad Plus Febuxostat Further Reduces Serum Uric Acid in Hyperuricemia: The QUARTZ Study

F. Erlandsson, J. Parkinson, J. Oscarsson, 2020, The Journal of clinical endocrinology and metabolism.

A Randomized, Double‐Blind, Placebo‐ and Positive‐Controlled, Three‐Way Crossover Study in Healthy Participants to Investigate the Effect of Savolitinib on the QTc Interval

Weili Yan, C. Dota, G. Ahmed, 2021, Clinical pharmacology in drug development.

Glucagon/GLP-1 receptor co-agonist NNC9204-1177 reduced body weight in adults with overweight or obesity but was associated with safety issues

S. Toubro, M. Friedrichsen, R. Goldwater, 2022, medRxiv.

Bioavailability of epinephrine from Auvi-Q compared with EpiPen.

Eric S. Edwards, V. Chinchilli, E. Simons, 2013, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Clinical evaluation of the potential drug–drug interactions of savolitinib: Interaction with rifampicin, itraconazole, famotidine or midazolam

G. Scarfe, W. Burke, K. Vishwanathan, 2021, British journal of clinical pharmacology.

AZD5634, an inhaled ENaC inhibitor, in healthy subjects and patients with cystic fibrosis.

A. Åstrand, S. Donaldson, C. Keen, 2022, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Gaucher disease, enzyme replacement therapy, and the Patient Assistance Program.

R. Goldwater, 1996, Journal of intravenous nursing : the official publication of the Intravenous Nurses Society.

Multiple ascending dose study of BMS‐790052, a nonstructural protein 5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1

Min Gao, Anna Persson, D. Grasela, 2011, Hepatology.

Single- and Multiple-Ascending-Dose Studies of the NS3 Protease Inhibitor Asunaprevir in Subjects with or without Chronic Hepatitis C

W. Kraft, D. Grasela, A. Persson, 2012, Antimicrobial Agents and Chemotherapy.

Proarrhythmic Safety of Repeat Doses of Mirabegron in Healthy Subjects: A Randomized, Double‐Blind, Placebo‐, and Active‐Controlled Thorough QT Study

M. Malik, S. Mujais, D. Kowalski, 2012, Clinical pharmacology and therapeutics.

Comparison of a Novel Formulation of Abiraterone Acetate vs. the Originator Formulation in Healthy Male Subjects: Two Randomized, Open-Label, Crossover Studies

R. Goldwater, A. Hussaini, Paul Nemeth, 2017, Clinical Pharmacokinetics.

AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer's Disease.

S. Haeberlein, L. Ereshefsky, S. Eketjäll, 2016, Journal of Alzheimer's disease : JAD.

Phase 1 Single‐ and Multiple‐Ascending‐Dose Randomized Studies of the Safety, Pharmacokinetics, and Pharmacodynamics of AG‐348, a First‐in‐Class Allosteric Activator of Pyruvate Kinase R, in Healthy Volunteers

C. Kung, Hua Yang, M. Goldwasser, 2018, Clinical pharmacology in drug development.

Single-and Multiple-Ascending-Dose Studies of the NS 3 Protease Inhibitor Asunaprevir in Subjects with or without Chronic Hepatitis C

W. Kraft, A. Persson, T. Marbury, 2012 .

Effect of food on capsule and granule formulations of selumetinib

Karen So, Sarit Cohen‐Rabbie, R. Goldwater, 2022, Clinical and translational science.

A comparative pharmacodynamic study of IY‐81149 versus omeprazole in patients with gastroesophageal reflux disease

A. Periclou, R. Goldwater, D. Park, 2000, Clinical pharmacology and therapeutics.

Phase 1, randomized, parallel, placebo‐controlled, safety, tolerance and pharmacokinetic study of multiple dose of IY‐81149 in fasting male volunteers

R. Goldwater, F. Boileau, S.M. Lee, 1999, Clinical Pharmacology & Therapeutics.

Pharmacokinetics and Immunogenicity of ASP0113 in CMV‐Seronegative Dialysis Patients and CMV‐Seronegative and ‐Seropositive Healthy Subjects

Larry R. Smith, P. Bonate, C. Van Sant, 2020, Clinical pharmacology in drug development.

Epinephrine 0.3 mg Bioavailability Following a Single Injection with a Novel Epinephrine Auto-injector, e-cue™, in Healthy Adults, with Reference to a Single Injection using EpiPen® 0.3 mg

Eric S. Edwards, V. Chinchilli, R. Goldwater, 2012 .

Characterization of a primate model of hypertension. The response of hypertensive and normotensive male vervets (Cercopithecus aethiops) to cold pressor stress, captopril administration, and acute bolus of atrial natriuretic factor.

R. Palmour, F. Ervin, P. Hamet, 1990, American journal of hypertension.

Pharmacokinetic Interactions Between Isavuconazole and the Drug Transporter Substrates Atorvastatin, Digoxin, Metformin, and Methotrexate in Healthy Subjects

D. Kowalski, K. Lasseter, T. Yamazaki, 2016, Clinical pharmacology in drug development.

A Phase I study evaluating the effect of age and weight on the pharmacokinetics of an injectable formulation of diclofenac solubilized with hydroxypropyl-β-cyclodextrin

D. Carr, P. Lacouture, Eric Lang, 2016, Clinical pharmacology : advances and applications.

Pharmacokinetics and Bioequivalence of Isavuconazole Administered as Isavuconazonium Sulfate Intravenous Solution via Nasogastric Tube or Orally in Healthy Subjects

R. Goldwater, A. Desai, S. Moy, 2021, Antimicrobial agents and chemotherapy.

A Phase I, Open-label, Randomized, Crossover Study of the Relative Bioavailability of Capsule and Granule Formulations of Selumetinib.

Nan Wang, Karen So, Sarit Cohen‐Rabbie, 2022, Clinical Therapeutics.

A phase 1 study to assess potential interaction between ASP8062 and alcohol in healthy adult subjects

G. Marek, P. Maruff, M. B. Blauwet, 2022, Journal of psychopharmacology.

AZD3293 A novel BACE1 inhibitor: safety, tolerability, and effects on plasma and CSF Aβ peptides following single- and multiple-dose administration

L. Ereshefsky, S. Budd, K. Elsby, 2014, Neurobiology of Aging.

Multiple ascending dose study of BMS‐790052, a nonstructural protein 5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1

D. Grasela, A. Persson, T. Marbury, 2011, Hepatology.

Proarrhythmic Safety of Repeat Doses of Mirabegron in Healthy Subjects: A Randomized, Double‐Blind, Placebo‐, and Active‐Controlled Thorough QT Study

S. Mujais, D. Kowalski, J. Keirns, 2012, Clinical pharmacology and therapeutics.